PL2852400T3 - An insulin analogue or its pharmaceutically acceptable salt, pharmaceutical composition with prolonged therapeutic effect, use of the insulin analogue, dosage method and method of treatment of diabetes - Google Patents

An insulin analogue or its pharmaceutically acceptable salt, pharmaceutical composition with prolonged therapeutic effect, use of the insulin analogue, dosage method and method of treatment of diabetes

Info

Publication number: PL2852400T3
Authority: PL; Poland
Prior art keywords: insulin analogue; diabetes; treatment; pharmaceutically acceptable; pharmaceutical composition
Prior art date: 2012-05-23

Application number

PL13730664T

Other languages

Polish (pl)

Inventor

Piotr Borowicz

Andrzej Plucienniczak

Jerzy Mikolajczyk

Jaroslaw Antosik

Jacek Pstrzoch

Justyna Bernat

Diana Mikiewicz

Monika Bogiel

Dorota Stadnik

Grazyna Plucienniczak

Bozena Tejchman-Malecka

Tadeusz Glabski

Iwona Sokolowska

Dariusz Kurzynoga

Anna Wojtowicz-Krawiec

Marcin Zielinski

Malgorzata Kesik-Brodacka

Natalia Lukasiewicz

Violetta Cecuda-Adamczewska

Monika Pawlowska

Tomasz Pawlukowiec

Jacek Stepniewski

Original Assignee

Inst Biotechnologii I Antybiotykow

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2012-05-23

Filing date

2013-05-22

Publication date

2017-10-31

2013-05-22 Application filed by Inst Biotechnologii I Antybiotykow filed Critical Inst Biotechnologii I Antybiotykow

2017-10-31 Publication of PL2852400T3 publication Critical patent/PL2852400T3/en

Links

NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical class N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 title 2
239000004026 insulin derivative Substances 0.000 title 2
206010012601 diabetes mellitus Diseases 0.000 title 1
239000008194 pharmaceutical composition Substances 0.000 title 1
230000002035 prolonged effect Effects 0.000 title 1
150000003839 salts Chemical class 0.000 title 1
230000001225 therapeutic effect Effects 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/28—Insulins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/62—Insulins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Diabetes (AREA)
Medicinal Chemistry (AREA)
Endocrinology (AREA)
General Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Gastroenterology & Hepatology (AREA)
Zoology (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Biophysics (AREA)
Epidemiology (AREA)
Immunology (AREA)
Molecular Biology (AREA)
Genetics & Genomics (AREA)
Toxicology (AREA)
Biochemistry (AREA)
Hematology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Obesity (AREA)
Emergency Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)

PL13730664T 2012-05-23 2013-05-22 An insulin analogue or its pharmaceutically acceptable salt, pharmaceutical composition with prolonged therapeutic effect, use of the insulin analogue, dosage method and method of treatment of diabetes PL2852400T3 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
PL399287A PL222975B1 (en)	2012-05-23	2012-05-23	Insulin analog or a pharmaceutically tolerated salt thereof, a pharmaceutical composition of prolonged therapeutic use of insulin analog, dosage and method for treatment of diabetes
PCT/PL2013/000066 WO2013176560A1 (en)	2012-05-23	2013-05-22	An insulin analogue or its pharmaceutically acceptable salt, pharmaceutical composition with prolonged therapeutic effect, use of the insulin analogue, dosage method and method of treatment of diabetes
EP13730664.3A EP2852400B1 (en)	2012-05-23	2013-05-22	An insulin analogue or its pharmaceutically acceptable salt, pharmaceutical composition with prolonged therapeutic effect, use of the insulin analogue, dosage method and method of treatment of diabetes

Publications (1)

Publication Number	Publication Date
PL2852400T3 true PL2852400T3 (en)	2017-10-31

Family

ID=48670747

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
PL399287A PL222975B1 (en)	2012-05-23	2012-05-23	Insulin analog or a pharmaceutically tolerated salt thereof, a pharmaceutical composition of prolonged therapeutic use of insulin analog, dosage and method for treatment of diabetes
PL13730664T PL2852400T3 (en)	2012-05-23	2013-05-22	An insulin analogue or its pharmaceutically acceptable salt, pharmaceutical composition with prolonged therapeutic effect, use of the insulin analogue, dosage method and method of treatment of diabetes

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
PL399287A PL222975B1 (en)	2012-05-23	2012-05-23	Insulin analog or a pharmaceutically tolerated salt thereof, a pharmaceutical composition of prolonged therapeutic use of insulin analog, dosage and method for treatment of diabetes

Country Status (5)

Country	Link
US (1)	US9585942B2 (en)
EP (1)	EP2852400B1 (en)
EA (1)	EA030519B1 (en)
PL (2)	PL222975B1 (en)
WO (1)	WO2013176560A1 (en)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3837825A1 (en)	1988-11-08	1990-05-10	Hoechst Ag	NEW INSULIN DERIVATIVES, THEIR USE AND A PHARMACEUTICAL PREPARATION CONTAINING THEM
DE19825447A1 (en)	1998-06-06	1999-12-09	Hoechst Marion Roussel De Gmbh	New insulin analogues with increased zinc formation
PL213561B1 (en)	2004-01-09	2013-03-29	Inst Biotechnologii I Antybiotykow	New plasmides, their derivatives and fragments, the method for their obtaining and application
PL373543A1 (en)	2005-03-10	2006-09-18	Instytut Biotechnologii i Antybiotyków	Pharmaceutical compound containing human insulin biosynthetic analogue as well as its application in diabetic treatment
PL219335B1 (en) *	2008-07-04	2015-04-30	Inst Biotechnologii I Antybiotyków	New slow-release insulin analogues

2012
- 2012-05-23 PL PL399287A patent/PL222975B1/en unknown
2013
- 2013-05-22 EP EP13730664.3A patent/EP2852400B1/en not_active Not-in-force
- 2013-05-22 PL PL13730664T patent/PL2852400T3/en unknown
- 2013-05-22 EA EA201492182A patent/EA030519B1/en not_active IP Right Cessation
- 2013-05-22 US US14/403,513 patent/US9585942B2/en not_active Expired - Fee Related
- 2013-05-22 WO PCT/PL2013/000066 patent/WO2013176560A1/en not_active Ceased

Also Published As

Publication number	Publication date
PL222975B1 (en)	2016-09-30
EP2852400B1 (en)	2017-04-12
US9585942B2 (en)	2017-03-07
WO2013176560A1 (en)	2013-11-28
EP2852400A1 (en)	2015-04-01
US20150164998A1 (en)	2015-06-18
PL399287A1 (en)	2013-11-25
EA201492182A1 (en)	2015-07-30
EA030519B1 (en)	2018-08-31

Similar Documents

Publication	Publication Date	Title
IL232251B (en)	2019-10-31	A pharmaceutical combination for use in the treatment of a diabetes type 2 patient
HUE043540T2 (en)	2019-08-28	Preparation and Use of Substituted Dimer Quinazoline Derivatives in Medicinal Products for the Treatment of Type 1 and Type 2 Diabetes
IL231536A (en)	2016-09-29	Indazole-3-carboxamides , pharmaceutical compositions comprising them and their use in the treatment of diseases
IL223783B (en)	2018-06-28	Substituted 1-indole compound for use in the treatment of a disease or condition, a pharmaceutical composition comprising the compound and use of the compound for the preparation of a medicament
MY174727A (en)	2020-05-11	Stable, protracted glp-1/glucagon receptor co-agonists for medical use
EP2782631A4 (en)	2015-08-26	Implantable solid-liquig drug delivery apparatus, formulations, and methods of use
IL235923A0 (en)	2015-01-29	Aminotriazolopyridine for use in the treatment of inflammation, and pharmaceutical compositions thereof
IL245429A0 (en)	2016-06-30	Pharmaceutical composition comprising glutarimide derivatives and use thereof in the treatment of eosinophilic diseases
ZA201508454B (en)	2017-02-22	Method of applying a composition and pharmaceutical composition with a regimen of administering it, including photo-activating the active component
FI20135152L (en)	2013-02-21	PHARMACEUTICAL COMPOUND COMPOSITION AND METHODS IN THE TREATMENT OF DIABETES AND METABOLIC DISEASES
EP3318879A4 (en)	2018-11-21	Gpc3-targeted therapeutic agent administered to patient in whom gpc3-targetd therapeutic ag
IL240949B (en)	2019-05-30	An aqueous pharmaceutical formulation for use in the treatment of type 1 or 2 diabetes mellitus
GB2497453B (en)	2017-07-12	Pharmaceutical composition and methods of treating and preventing the diseases caused by HIV or associated with HIV
IL245738A0 (en)	2016-08-02	Oxindole derivatives, preparation thereof and therapeutic use in the treatment of ampk-related diseases
EP3015111A4 (en)	2017-03-01	Use of chinese medicine preparation in preparing drug for preventing and/or treating crohn's disease
WO2014153385A3 (en)	2014-11-13	Methods of treating metabolic disorders
PH12016502233A1 (en)	2017-02-06	(s)-pirlindole or its pharmaceutically acceptable salts for use in medicine
PH12016502236A1 (en)	2017-02-06	(r)-pirlindole and its pharmaceutically acceptable salts for use in medicine
PL2852400T3 (en)	2017-10-31	An insulin analogue or its pharmaceutically acceptable salt, pharmaceutical composition with prolonged therapeutic effect, use of the insulin analogue, dosage method and method of treatment of diabetes
BR112014014289A2 (en)	2017-06-13	diabetes treatment method, formulation for oral administration, composition, and use of any or more of the phenoxypyrimidinone and insulin compounds
SG11201501043TA (en)	2015-04-29	Pharmaceutical composition for oral administration with improved dissolution and/or absorption
ZA201600894B (en)	2017-05-31	Use of 3-carboxy-n-ethyl-n,n-dimethylpropan-1-aminium or a pharmaceutically acceptable salt thereof in the prevention and treatment of diabetes
HK1193342A (en)	2014-09-19	Pharmaceutical combination for use in the treatment of diabetes type 2
IN2014DE00818A (en)	2015-09-25
GB201304462D0 (en)	2013-04-24	Therapeutic vaccine for treatment of type 2 diabetes and impaired glucose tolerance